One of the most surprising compliance hurdles comes from the inconsistency not just between states but within individual regulatory bodies over time. What passes inspection in one state might trigger penalties in another. Even when expanding into medically legal states, the interpretation of telehealth laws and patient verification protocols shifts. We've had to pause launches, retrain staff, and adjust core workflows overnight based on legal opinions. State portals change without notice. Enforcement trends swing depending on leadership. The patchwork never holds for long. Product offerings change drastically. Some states allow flower, others restrict it to capsules or oils. Dosage caps, packaging rules, and approved conditions for treatment all fluctuate. In one state, PTSD is approved, in the next, it's not. This impacts not just what we offer but how we speak to patients, what documentation we require, and how providers conduct evaluations. Uniformity is impossible. Personalization and agility are the only ways forward. We operate across multiple states. Compliance is not a one-time event, it's a daily practice. We built an internal compliance operations team that reviews every policy update, and every state board notice, and audits our workflows weekly. We lean hard on localized legal consultants. Technology helps us scale without slipping. Our platform integrates directly with HIPAA-compliant video tools, state verification systems, and secure record storage. It's the only way to stay ahead of both scrutiny and service demands. Federal legalization would reduce redundancy and waste. It wouldn't remove every challenge, but it would eliminate the need to start from scratch in every state.